[(8R,9S,13S,14S,17R)-13-methyl-3-propanoyloxy-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] propanoate

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 类固醇和类固醇衍生物
• 英文名称: [(8R,9S,13S,14S,17R)-13-methyl-3-propanoyloxy-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] propanoate
• 化学式: C₂₄H₃₂O₄
• 分子量: 384.5
• InChiKey: JQIYNMYZKRGDFK-IDYLKPADSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.3
• 重原子数：
  28
• 可旋转键数：
  6
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.67
• 拓扑面积：
  52.6
• 氢给体数：
  0
• 氢受体数：
  4

文献信息

• Drug delivery system for sustained delivery of bioactive agents
  申请人：UPM-Kymmene Corporation

  公开号：US11389537B2

  公开（公告）日：2022-07-19

  A drug delivery system for sustained delivery of bioactive agents, the system includes a matrix including nanofibrillated cellulose derived from plant based material and at least one bioactive agent, and at least one support selected from synthetic polymers, bio compounds and natural polymers. Also, methods for the manufacture of the system and methods of using it.

  一种用于持续递送生物活性剂的给药系统，该系统包括一种基质，其中包括从植物基材料中提取的纳米纤维素和至少一种生物活性剂，以及至少一种选自合成聚合物、生物化合物和天然聚合物的支持物。此外，还有该系统的制造方法和使用方法。
• DRUG DELIVERY SYSTEM FOR SUSTAINED DELIVERY OF BIOACTIVE AGENTS
  申请人：UPM-Kymmene Corporation

  公开号：EP2779996A1

  公开（公告）日：2014-09-24
• DRUG DELIVERY SYSTEM FOR ULTRA-LOW DOSE ESTROGEN COMBINATIONS AND METHODS AND USES THEREOF
  申请人：Lupin Inc.

  公开号：US20200179274A1

  公开（公告）日：2020-06-11

  The invention relates to a drug delivery system for contraception including a steroidal estrogenic compound, a steroidal progestogenic compound or a combination thereof for the purposes of contraception in a subject, and provides for an ultra-low dose delivery of a steroidal estrogenic compound. The invention also relates to a method of contraception using the drug delivery system and method of manufacturing the drug delivery system.
• US4215691A
  申请人：——

  公开号：US4215691A

  公开（公告）日：1980-08-05
• US4237885A
  申请人：——

  公开号：US4237885A

  公开（公告）日：1980-12-09